Cours Aequus Pharmaceuticals Inc Toronto S.E.
Actions
CA0076361033
Produits pharmaceutiques
CA 2022 | 1,38 M 1,01 M 922 k | CA 2023 | 255 k 187 k 170 k | Capitalisation | 3,32 M 2,43 M 2,22 M |
---|---|---|---|---|---|
Résultat net 2022 | -3 M -2,2 M -2 M | Résultat net 2023 | -2 M -1,47 M -1,34 M | VE / CA 2022 | 5,17 x |
Dette nette 2022 | 2,49 M 1,82 M 1,66 M | Dette nette 2023 | 4,85 M 3,55 M 3,24 M | VE / CA 2023 | 32 x |
PER 2022 |
-1,45
x | PER 2023 |
-1,12
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 85,32% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 01/01/13 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 22/07/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Marc Lustig
BRD | Director/Board Member | 51 | 15/02/21 |
Director/Board Member | 54 | 18/12/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+37,78% | 723 Md | |
+32,82% | 598 Md | |
-3,51% | 364 Md | |
+19,94% | 331 Md | |
+5,14% | 288 Md | |
+16,64% | 244 Md | |
-4,13% | 208 Md | |
+10,63% | 210 Md | |
+9,32% | 169 Md |